The GLP-1 drug market has surged dramatically in the past four years, driven by soaring demand for weight-loss treatments ...

Viking Therapeutics is nearing the finish line with a candidate for weight loss -- to potentially enter a drug market that’s approaching $100 billion. This biotech has candidates in phase 2 and phase ...

Viking Therapeutics (VKTX) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the ...

Viking Therapeutics (NASDAQ: VKTX) is set to give its latest quarterly earnings report on Wednesday, 2025-10-22. Here's what investors need to know before the announcement. Analysts estimate that ...

After the game ended in regulation with a 6-6 tie, R. J. Reynolds won the coin toss in overtime and deferred giving the ...

Another week, another two goals for the Viking. That’s become so run of the mill that what really caught our eye was vision of him dressed up as The Joker for Halloween going into the local shops ...

A metal detectorist convicted of stealing part of a Viking hoard valued at £3m is back in jail after not paying back his ...

Viking on Thursday reported a third-quarter loss per share of $0.81, compared to the expected loss of $0.7 per share. ・Morgan ...

The upward momentum in the equity market is likely to continue heading into the year-end. It is a stance held by major ...